By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

SARS-CoV2 vaccination: Thrombosis can be prevented by prompt treatment

researcher in protection suit, microscope © Medical University of Vienna

This involves thrombosis at unusual places in the body, associated with a low thrombocyte (blood platelet) count and a clotting disorder. In medical jargon, this syndrome is referred to as VITT (vaccine-induced thrombotic thrombocytopenia) or a vaccine-caused shortage of blood platelets. The VITT syndrome is most probably caused by a defective immune response, whereby thrombocyte-activating antibodies are produced resulting in thrombocytopenia (low platelet count) and thrombosis. The mortality rate in VITT is high (40-50 percent) and the syndrome requires immediate and appropriate treatment.

A team of doctors at the Department of Internal Medicine of the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital successfully treated a patient suffering from vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). The female patient was admitted to the department with a low platelet count and low fibrinogen levels, but still without a thrombosis. Fibrinogen is a protein that plays a major role in blood clotting. Indications of an impending thrombosis were extremely high, and doctors immediately began treatment with a high dose of intravenous immunoglobulin concentrates, cortisone and specific anticoagulants, so that thrombosis was prevented. These new findings were published in the Journal of Thrombosis and Haemostasis.

Read on and find out more about renowned research institutions in Austria!

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us @ BIO-Europe

    25.10.2021 - 28.10.2021/ 07.30am - 06.00pm, Virtual Event

Austria Map

Find the perfect location for your company

Vienna’s unique location at the heart of Europe makes it an important centre and very popular with the global pharmaceutical and biotechnology industry. Vienna is where Eastern Europe meets Western Europe. Businesses located at this international hub benefit from well-established infrastructures and highly-qualified professionals. The significant growth in the Life Sciences sector in Vienna over the last few years is an indicator of the momentum in the industry.

ABF Pharmaceutical Services

ABF Pharmaceutical Services
More testimonials

news from the business location Austria

Austria stands out due to its tax incentives for research

You want to know why companies such as Infineon, Siemens and Bosch have been carrying out research in Austria for decades? Contact us.

Lynus – the software for the enegery-optimized building of the future.

The business location Austria offers innovative businesses such as Lynus the right platform, a modern environment, and highly skilled workforce in order to use complex IOT solutions with ease. Additionally the desire of a lot of Austrian companies to minimize their CO2 footprint in a sustainable way, appeals very much to our business model.

More news All blog posts